Aortic calcifications in familial hypercholesterolemia: Potential role of the low-density lipoprotein receptor gene

American Heart Journal

Volumn 157, Issue 1, 2009, Pages 170-176

  Alrasadi, Khalid ^a   Alwaili, Khalid ^a   Awan, Zuhier ^a   Valenti, David ^a   Couture, Patrick ^a   Genest, Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE DOSAGE; GENE MUTATION; HETEROZYGOTE; HETEROZYGOTE FH; HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR GENE; MALE; NULL ALLELE; PRIORITY JOURNAL;

ADULT; AGED; AORTIC DISEASES; CALCINOSIS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; RECEPTORS, LDL; YOUNG ADULT;

EID: 57149095250     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.08.021     Document Type: Article

References (42)

1. Goldstein J.L., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., et al. (Ed). The metabolic basis of inherited disease. 6th ed. (1989), McGraw Hill, New York 1215-1250
2. Abifadel M., Varret M., Rabes J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34 (2003) 154-156
3. Vega G.L., and Grundy S.M. In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J Clin Invest 78 (1986) 1410-1414
4. Garcia C.K., Wilund K., Arca M., et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292 (2001) 1394-1398
5. Goldstein J.L., Schrott H.G., Hazzard W.R., et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
6. Tosi I., Toledo-Leiva P., Neuwirth C., et al. Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis 194 (2007) 102-111
7. Moorjani S., Roy M., Gagne C., et al. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 2 (1989) 211-216
8. Scriver C.R. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2 (2001) 69-101 [Review]
9. Grenon S.M., Lachapelle K., Marcil M., et al. Surgical strategies for severe. calcification of the aorta (porcelain aorta) in two patients with homozygous familial hypercholesterolemia. Can J Cardiol 23 (2007) 1159-1161
10. Awan Z., Alrasadi K., Francis G.A., et al. Vascular calcifications in homozygote familial hypercholesterolemia: the Canadian experience. Atheroscler Thromb Vasc Biol (2008)
11. Thompson G.R., Miller J.P., and Breslow J.L. Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange. Br Med J (Clin Res Ed) 291 (1985) 1671-1673
12. Naoumova R.P., Thompson G.R., and Soutar A.K. Current management of severe homozygous hypercholesterolaemias. Curr Opin Lipidol 15 (2004) 413-422 [Review]
13. Thompsen J., and Thompson P.D. A systematic review of LDL apheresis in the treatment of cardiovascular disease. Atherosclerosis 189 (2006) 31-38 [electronic publication 2006 Mar 20]
14. West R., Gibson P., and Lloyd J. Treatment of homozygous familial hypercholesterolaemia: an informative sibship. Br Med J (Clin Res Ed) 291 (1985) 1079-1080
15. Leren T.P., Fagerhol M.K., and Leren P. Sixteen years of plasma exchange in a homozygote for familial hypercholesterolaemia. J Intern Med 233 (1993) 195-200
16. Kawaguchi A., Miyatake K., Yutani C., et al. Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. Am Heart J 137 (1999) 410-418
17. Kawaguchi A., Yutani C., and Yamamoto A. Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis. Ther Apher Dial 7 (2003) 439-443
18. Sprecher D.L., Schaefer E.J., Kent K.M., et al. Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 54 (1984) 20-30
19. Brook G.J., Keidar S., Boulos M., et al. Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patients. Clin Cardiol 12 (1989) 333-338
20. Moorjani S., Roy M., Torres A., et al. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 341 (1993) 1303-1306
21. Saito S., Usui A., Akita T., et al. Surgery for calcific aortic root stenosis in homozygous familial hypercholesterolemia. Eur J Cardiothorac Surg 29 (2006) 114-116
22. Elghobary T., Allal J., Menu P., et al. Homograft replacement of the calcified aortic root in familial hypercholesterolemia. Ann Thorac Surg 81 (2006) e4-e5
23. Yasuda T., Kawasuji M., Sakakibara N., et al. Aortic valve replacement for the calcified ascending aorta in homozygous familial hypercholesterolemia. Eur J Cardiothorac Surg 18 (2000) 249-250
24. Aubert S., Bonnet N., Leprince P., et al. Surgical approach to aortic root lesions in patients with homozygous familial hypercholesterolemia and Takayasu arteritis. J Thorac Cardiovasc Surg 130 (2005) 573-574
25. Stary H.C. The development of calcium deposits an atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 88 (2001) 16E-19E
26. Abedin M., Tintut Y., and Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24 (2004) 1161-1170 [Epub 2004 May 20. Review]
27. Johnson R.C., Leopold J.A., and Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99 (2006) 1044-1059
28. Vohl M.C., Moorjani S., Roy M., et al. Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec. Clin Genet 52 (1997) 1-6
29. Simard L.R., Viel J., Lambert M., et al. The Δ>15 kb deletion French Canadian founder mutation in familial hypercholesterolemia: rapid polymerase chain reaction-based diagnostic assay and prevalence in Quebec. Clin Genet 65 (2004) 202-208
30. Schmidt H.H., Hill S., Makariou E.V., et al. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 77 (1996) 575-580
31. Houslay E.S., Cowell S.J., Prescott R.J., et al. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart 92 (2006) 1207-1212
32. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352 (2005) 2389-2397
33. Haitas B., Baker S.G., Meyer T.E., et al. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia. Q J Med 76 (1990) 731-740
34. Steitz S.A., Speer M.Y., Curinga G., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89 (2001) 1147-1154
35. O'Brien K.D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26 (2006) 1721-1728
36. Shao J.S., Cai J., and Towler D.A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 26 (2006) 1423-1430
37. Rajamannan N.M., Subramaniam M., Springett M., et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 105 (2002) 2660-2665
38. Rajamannan N.M., Subramaniam M., Rickard D., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107 (2003) 2181-2184
39. Giachelli C.M. Vascular calcification mechanisms. J Am Soc Nephrol 15 (2004) 2959-2964
40. Weiss R.M., Ohashi M., Miller J.D., et al. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 114 (2006) 2065-2069
41. Genest Jr. J., and Lavoie M.-A. Homozygous familial hypercholesterolemia. Images in Clinical Medicine. New Engl J Med 341 (1999) 490
42. Davila J.A., Johnson C.D., Behrenbeck T.R., et al. Assessment of cardiovascular risk status at CT colonography. Radiology 240 (2006) 110-115